Uncovering the protective mechanism of baicalin in treatment of fatty liver based on network pharmacology and cell model of NAFLD
International Immunopharmacology · 2024
DOI: 10.1016/j.intimp.2024.112954 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Immunopharmacology, 2024. Verfasst von Yongqiang Wen und 6 weiteren Autor:innen. Beteiligte Einrichtung: College of Veterinary Medicine, Northwest A&F University, Yangling 712100, China. Hauptthemen laut MEDLINE: Flavonoids, Non-alcoholic Fatty Liver Disease, Hepatocytes, Network Pharmacology. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 85 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Northwest A&F University.
Abstract (Originalsprache)
Excessive nonesterified fatty acids (NEFA) impair cellular metabolism and will induce fatty liver formation in dairy cows during the periparturient. Baicalin, an active flavonoid, has great potential efficacy in alleviating lipid accumulation and ameliorating the development of fatty liver disease. Nevertheless, its mechanism remains unclear. Here, the potential mechanism of baicalin on system levels was explored using network pharmacology and in vitro experiments. Firstly, the target of baicalin and fatty liver disease was predicted, and then the protein-protein interaction (PPI) network was constructed. In addition, the Kyoto Encyclopedia of Genes and Genomes (KEGG) (q-value) pathway enrichment is performed through the Database for Annotation, Visualization, and Integrated Discovery (DAVID) server. Finally, the results of the network analysis of the in vitro treatment of bovine hepatocytes by NEFA were confirmed. The results showed that 33 relevant targets of baicalin in the treatment of liver fatty were predicted by network pharmacology, and the top 20 relevant pathways were extracted by KEGG database. Baicalin treatment can reduce triglyceride (TAG) content and lipid droplet accumulation in NEFA-treated bovine hepatocytes, and the mechanism is related to inhibiting lipid synthesis and promoting lipid oxidation. The alleviating effect of baicalin on fatty liver may be related to the up-regulation of solute vector family member 4 (SLC2A4), Down-regulated AKT serine/threonine kinase 1 (AKT1), Peroxisome proliferator-activated receptor gamma (PPARG), Epidermal growth factor receptor (EGFR), tumor necrosis factor (TNF), Interleukin 6 (IL-6) were associated. These results suggested that baicalin may modulate key inflammatory markers, and lipogenesis processes to prevent fatty liver development in dairy cows.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Veterinary Medicine, Northwest A&F University, Yangling 712100, China.
- College of Veterinary Medicine, Northwest A&F University, Yangling 712100, China. Electronic address: jgwang0625@nwsuaf.edu.cn.
Förderung
- National Natural Science Foundation of China
- Northwest A&F University
Zitieren
APA
Wen, Y., Yi, F., Zhang, J., Wang, Y., Zhao, C., Zhao, B., & Wang, J. (2024). Uncovering the protective mechanism of baicalin in treatment of fatty liver based on network pharmacology and cell model of NAFLD. International Immunopharmacology. https://doi.org/10.1016/j.intimp.2024.112954
Vancouver
Wen Y, Yi F, Zhang J, Wang Y, Zhao C, Zhao B, et al. Uncovering the protective mechanism of baicalin in treatment of fatty liver based on network pharmacology and cell model of NAFLD. International Immunopharmacology. 2024. doi:10.1016/j.intimp.2024.112954
BibTeX
@article{Wen2024,
author = {Wen, Yongqiang and Yi, Fanxuan and Zhang, Jia and Wang, Yazhou and Zhao, Chenxu and Zhao, Baoyu and Wang, Jianguo},
title = {Uncovering the protective mechanism of baicalin in treatment of fatty liver based on network pharmacology and cell model of NAFLD},
journal = {International Immunopharmacology},
year = {2024},
doi = {10.1016/j.intimp.2024.112954}
}
EUVIMED